Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1)

LA Dowd, AJ Coyle, JD Rothstein, DB Pritchett and MB Robinson

The Children's Seashore House, Children's Hospital of Philadelphia, Pennsylvania, 19104, USA.

Several subtypes of sodium-dependent high affinity (SDHA) glutamate transporters have been pharmacologically differentiated in brain tissue. Recently, four distinct cDNAs (EAAC1, GLT1, GLAST, and EAAT4) encoding Na+-dependent glutamate transporters have been isolated, but the properties of some of these transporters do not fully match the properties of transport observed in brain tissue or astrocyte-enriched cultures. The purpose of the current investigation was to determine whether the pharmacological properties of EAAC1 parallel those observed in cortical or cerebellar synaptosomes, C6 glioma, or primary astrocyte- enriched cultures. EAAC1 cRNA was expressed in Xenopus oocytes, an expression system with no detectable endogenous Na+-dependent glutamate transport activity. EAAC1-mediated glutamate transport was >98% Na+ dependent, and the transport was saturable and consistent with a single site. Glutamate transport activates in EAAC1-injected oocytes and C6 glioma have similar Km values for glutamate (Km = 15-24 microM) and Na+ (apparent Km = 35-50mM), and these values markedly differ from those observed in rat synaptosomes (glutamate, Km = 1-5 microM; Na+, Km = 13- 20 mM). Several excitatory amino acid analogues were tested as inhibitors of L-[3H] glutamate transport in oocytes expressing EAAC1 cRNA. The potencies of several compounds for inhibition of EAAC1- mediated transport differed from those previously observed in cerebellar synaptosomes and astrocyte-enriched cultures. Although EAAC1- mediated transport and cortical synaptosomal transport have similar pharmacological profiles, five excitatory amino acid analogues were > or= 3-fold more potent as inhibitors of transport into cortical synaptosomes than of transport into EAAC1-injected oocytes. For example, L-trans-pyrrolidine-2,4-dicarboxylate was approximately 5-fold more potent in cortical synaptosomes, and dihydrokainate was approximately 10-fold more potent in cortical synaptosomes than in EAAC1-injected oocytes. In contrast, all of the compounds examined inhibit transport observed in C6 glioma wtih potencies similar to that observed in oocytes injected with EAAC1 cRNA. Consistent with these data, C6 glioma expressed EAAC1- but not GLT1- and GLAST-like immunoreactivity. Although this immunoreactivity migrated as proteins of slightly different molecular masses in each system, treatment with N- glycosidase F shifted all proteins to a molecular mass consistent with that predicted from the cDNA sequence. In cortical synaptosomes, EAAC1- , GLT1-, and GLAST-like immunoreactives were apparent. These results indicate that (i) EAAC1 but not GLAST or GLT1 transporters are expressed in C6 glioma, (ii) synaptosomes contain a heterogeneous population of transporters, (iii) EAAC1 does not account for the pharmacology previously observed in cortical synaptosomes, and (iv) based on the pharmacology and tissue distribution of EAAC1, GLT1, GLAST, and EAAT4, it appears that there are additional glutamate transporter subtypes.

Volume 49, Issue 3, pp. 465-473, 03/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Misonou, S. M. Thompson, and X. Cai Dynamic Regulation of the Kv2.1 Voltage-Gated Potassium Channel during Brain Ischemia through Neuroglial Interaction J. Neurosci., August 20, 2008; 28(34): 8529 - 8538. [Abstract] [Full Text] [PDF]

				M. A. Herman and C. E. Jahr Extracellular Glutamate Concentration in Hippocampal Slice J. Neurosci., September 5, 2007; 27(36): 9736 - 9741. [Abstract] [Full Text] [PDF]

				M. Dallas, H. E. Boycott, L. Atkinson, A. Miller, J. P. Boyle, H. A. Pearson, and C. Peers Hypoxia Suppresses Glutamate Transport in Astrocytes J. Neurosci., April 11, 2007; 27(15): 3946 - 3955. [Abstract] [Full Text] [PDF]

				Y.-X. Yu, L. Shen, P. Xia, Y.-W. Tang, L. Bao, and G. Pei Syntaxin 1A promotes the endocytic sorting of EAAC1 leading to inhibition of glutamate transport. J. Cell Sci., September 15, 2006; 119(Pt 18): 3776 - 3787. [Abstract] [Full Text] [PDF]

				D. V. Dabir, M. B. Robinson, E. Swanson, B. Zhang, J. Q. Trojanowski, V. M.-Y. Lee, and M. S. Forman Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes J. Neurosci., January 11, 2006; 26(2): 644 - 654. [Abstract] [Full Text] [PDF]

				M. Funicello, P. Conti, M. De Amici, C. De Micheli, T. Mennini, and M. Gobbi Dissociation of [3H]L-Glutamate Uptake from L-Glutamate-Induced [3H]D-Aspartate release by 3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic Acid and 3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic Acid, Two Conformationally Constrained Aspartate and Glutamate Analogs Mol. Pharmacol., September 1, 2004; 66(3): 522 - 529. [Abstract] [Full Text] [PDF]

				K. M. Fournier, M. I. Gonzalez, and M. B. Robinson Rapid Trafficking of the Neuronal Glutamate Transporter, EAAC1: EVIDENCE FOR DISTINCT TRAFFICKING PATHWAYS DIFFERENTIALLY REGULATED BY PROTEIN KINASE C AND PLATELET-DERIVED GROWTH FACTOR J. Biol. Chem., August 13, 2004; 279(33): 34505 - 34513. [Abstract] [Full Text] [PDF]

				Y. H. Huang, S. R. Sinha, K. Tanaka, J. D. Rothstein, and D. E. Bergles Astrocyte Glutamate Transporters Regulate Metabotropic Glutamate Receptor-Mediated Excitation of Hippocampal Interneurons J. Neurosci., May 12, 2004; 24(19): 4551 - 4559. [Abstract] [Full Text] [PDF]

				R. Schniepp, K. Kohler, T. Ladewig, E. Guenther, G. Henke, M. Palmada, C. Boehmer, J. D. Rothstein, S. Broer, and F. Lang Retinal Colocalization and In Vitro Interaction of the Glutamate Receptor EAAT3 and the Serum- and Glucocorticoid-Inducible Kinase SGK1 Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1442 - 1449. [Abstract] [Full Text] [PDF]

				A. Furuta, M. Noda, S. O. Suzuki, Y. Goto, Y. Kanahori, J. D. Rothstein, and T. Iwaki Translocation of Glutamate Transporter Subtype Excitatory Amino Acid Carrier 1 Protein in Kainic Acid-Induced Rat Epilepsy Am. J. Pathol., August 1, 2003; 163(2): 779 - 787. [Abstract] [Full Text] [PDF]

				Y. Sadzuka, Y. Yamashita, and T. Sonobe Effects of Glutamate Transporter Inhibitors on the Antitumor Activity of Doxorubicin Clin. Cancer Res., December 1, 2002; 8(12): 3943 - 3947. [Abstract] [Full Text] [PDF]

				A. Kalandadze, Y. Wu, and M. B. Robinson Protein Kinase C Activation Decreases Cell Surface Expression of the GLT-1 Subtype of Glutamate Transporter. REQUIREMENT OF A CARBOXYL-TERMINAL DOMAIN AND PARTIAL DEPENDENCE ON SERINE 486 J. Biol. Chem., November 22, 2002; 277(48): 45741 - 45750. [Abstract] [Full Text] [PDF]

				W. Yang and M. S. Kilberg Biosynthesis, Intracellular Targeting, and Degradation of the EAAC1 Glutamate/Aspartate Transporter in C6 Glioma Cells J. Biol. Chem., October 4, 2002; 277(41): 38350 - 38357. [Abstract] [Full Text] [PDF]

				I. S. Ramsey and L. J. DeFelice Serotonin Transporter Function and Pharmacology Are Sensitive to Expression Level. EVIDENCE FOR AN ENDOGENOUS REGULATORY FACTOR J. Biol. Chem., April 19, 2002; 277(17): 14475 - 14482. [Abstract] [Full Text] [PDF]

				H. P. Koch, M. P. Kavanaugh, C. S. Esslinger, N. Zerangue, J. M. Humphrey, S. G. Amara, A. R. Chamberlin, and R. J. Bridges Differentiation of Substrate and Nonsubstrate Inhibitors of the High-Affinity, Sodium-Dependent Glutamate Transporters Mol. Pharmacol., December 1, 1999; 56(6): 1095 - 1104. [Abstract] [Full Text]

				J. Masson, C. Sagne, M. Hamon, and S. E. Mestikawy Neurotransmitter Transporters in the Central Nervous System Pharmacol. Rev., September 1, 1999; 51(3): 439 - 464. [Abstract] [Full Text] [PDF]

				J. Tan, O. Zelenaia, D. Correale, J. D. Rothstein, and M. B. Robinson Expression of the GLT-1 Subtype of Na+-Dependent Glutamate Transporter: Pharmacological Characterization and Lack of Regulation by Protein Kinase C J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1600 - 1610. [Abstract] [Full Text]

				K. E. Davis, D. J. Straff, E. A. Weinstein, P. G. Bannerman, D. M. Correale, J. D. Rothstein, and M. B. Robinson Multiple Signaling Pathways Regulate Cell Surface Expression and Activity of the Excitatory Amino Acid Carrier 1 Subtype of Glu Transporter in C6 Glioma J. Neurosci., April 1, 1998; 18(7): 2475 - 2485. [Abstract] [Full Text] [PDF]

				J. C. Matthews, M. J. Beveridge, M. S. Malandro, J. D. Rothstein, M. Campbell-Thompson, J. W. Verlander, M. S. Kilberg, and D. A. Novak Activity and protein localization of multiple glutamate transporters in gestation day 14 vs. day 20 rat placenta Am J Physiol Cell Physiol, March 1, 1998; 274(3): C603 - C614. [Abstract] [Full Text] [PDF]

				S. Eliasof, J. L. Arriza, B. H. Leighton, M. P. Kavanaugh, and S. G. Amara Excitatory Amino Acid Transporters of the Salamander Retina: Identification, Localization, and Function J. Neurosci., January 15, 1998; 18(2): 698 - 712. [Abstract] [Full Text] [PDF]

				G. J. Wang, H. J. Chung, J. Schnuer, K. Pratt, A. C. Zable, M. P. Kavanaugh, and P. A. Rosenberg High Affinity Glutamate Transport in Rat Cortical Neurons in Culture Mol. Pharmacol., January 1, 1998; 53(1): 88 - 96. [Abstract] [Full Text]

				R. G. Knickelbein, T. Seres, G. Lam, R. B. Johnston Jr., and J. B. Warshaw Characterization of multiple cysteine and cystine transporters in rat alveolar type II cells Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1147 - L1155. [Abstract] [Full Text] [PDF]

				R. A. Swanson, J. Liu, J. W. Miller, J. D. Rothstein, K. Farrell, B. A. Stein, and M. C. Longuemare Neuronal Regulation of Glutamate Transporter Subtype Expression in Astrocytes J. Neurosci., February 1, 1997; 17(3): 932 - 940. [Abstract] [Full Text] [PDF]